We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx®protein expression system

Publications show all

Protalix Biotherapeutics has published 13 articles.

Clinical Trials show all

1Phase 1/Phase 21Phase 4

SEC Filings show all

8-K19110-Q3910-K15